Soleus Capital Management’s Geron GERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$54.8M Buy
42,808,659
+1,300,000
+3% +$1.83M 1.89% 13
2026
Q1
$61.8M Buy
41,508,659
+18,218,659
+78% +$27.7M 2.5% 12
2025
Q4
$30.7M Buy
23,290,000
+6,000,000
+35% +$7.53M 1.13% 23
2025
Q3
$23.7M Buy
17,290,000
+1,150,000
+7% +$1.53M 1.19% 25
2025
Q2
$22.8M Buy
16,140,000
+13,740,000
+573% +$19.5M 1.51% 22
2025
Q1
$3.82M Buy
+2,400,000
New +$5.84M 0.27% 53

Other funds holding GERN

Soleus Capital Management's GERN Position: Q2 2026 in Review

Soleus Capital Management increased its Geron (GERN) stake by 3.1% in Q2 2026, buying an estimated $1.83M and bringing the position to 42,808,659 shares worth $54.8M. The position accounts for 1.89% of the portfolio, ranked #13.

Soleus Capital Management first reported a position in GERN in Q1 2025 and has held it in 6 quarters since. The position peaked at $61.8M in Q1 2026. 259 funds tracked by Wall St. Rank hold GERN as of Q2 2026.

  • Soleus Capital Management held 42,808,659 shares of Geron worth $54.8M as of Q2 2026.
  • Soleus Capital Management bought 1,300,000 Geron shares in Q2 2026, an estimated $1.83M.
  • Geron made up 1.89% of Soleus Capital Management's portfolio in Q2 2026, its #13 holding.
  • Soleus Capital Management first reported a position in Geron in Q1 2025 and has held it in 6 quarters since.
  • Soleus Capital Management's Geron position peaked at $61.8M in Q1 2026.
  • 259 funds tracked by Wall St. Rank held Geron as of Q2 2026.

Based on Soleus Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.